Constadina Arvanitis, Ph.D.
Affiliations: | 2008 | Stanford University, Palo Alto, CA |
Area:
OncologyGoogle:
"Constadina Arvanitis"Parents
Sign in to add mentor| Dean W. Felsher | grad student | 2008 | Stanford | |
| (Consequences of MYC inactivation in conditional mouse models: A study of mechanisms responsible for sustained tumor regression.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sima LE, Yakubov B, Zhang S, et al. (2019) Small Molecules Target the Interaction between Tissue Transglutaminase and Fibronectin. Molecular Cancer Therapeutics |
| Markwell S, Ross J, Olson C, et al. (2019) TMOD-37. INTRAVITAL MONITORING DYNAMIC TUMOR MICRO-ENVIRONMENTAL EVOLUTION FOLLOWING HYPOXIA-INDUCED NECROSIS IN GLIOBLASTOMA Neuro-Oncology. 21: vi271-vi271 |
| Eckerdt F, Alvarez A, Bell J, et al. (2016) A simple, low-cost staining method for rapid-throughput analysis of tumor spheroids. Biotechniques. 60: 43-6 |
| Arvanitis C, Khuon S, Spann R, et al. (2014) Structure and biomechanics of the endothelial transcellular circumferential invasion array in tumor invasion Plos One. 9 |
| Pichot CS, Arvanitis C, Hartig SM, et al. (2010) Cdc42-interacting protein 4 promotes breast cancer cell invasion and formation of invadopodia through activation of N-WASp. Cancer Research. 70: 8347-56 |
| Pichot CS, Hartig SM, Xia L, et al. (2009) Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cells. British Journal of Cancer. 101: 38-47 |
| Arvanitis C, Bendapudi PK, Tseng JR, et al. (2008) (18)F and (18)FDG PET imaging of osteosarcoma to non-invasively monitor in situ changes in cellular proliferation and bone differentiation upon MYC inactivation. Cancer Biology & Therapy. 7: 1947-51 |
| Wu CH, Sahoo D, Arvanitis C, et al. (2008) Combined analysis of murine and human microarrays and ChIP analysis reveals genes associated with the ability of MYC to maintain tumorigenesis. Plos Genetics. 4: e1000090 |
| Arvanitis C, Bendapudi PK, Bachireddy P, et al. (2007) Identifying critical signaling molecules for the treatment of cancer. Recent Results in Cancer Research. Fortschritte Der Krebsforschung. ProgrèS Dans Les Recherches Sur Le Cancer. 172: 5-24 |
| Arvanitis C, Felsher DW. (2006) Conditional transgenic models define how MYC initiates and maintains tumorigenesis. Seminars in Cancer Biology. 16: 313-7 |